Recent advances in topical delivery of proteins and peptides mediated by soft matter nanocarriers.
暂无分享,去创建一个
Sarah Hedtrich | W. Friess | S. Hedtrich | M. Witting | K. Obst | Wolfgang Friess | Madeleine Witting | Katja Obst
[1] Xiuli Wang,et al. Solid lipid nanoparticles for pulmonary delivery of insulin. , 2008, International journal of pharmaceutics.
[2] B. Sarmento,et al. Nanocarriers for pulmonary administration of peptides and therapeutic proteins. , 2011, Nanomedicine.
[3] Ching-Hua Wang,et al. Pulmonary delivery of insulin by liposomal carriers. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[4] J. Hanes,et al. Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. , 2009, Advanced drug delivery reviews.
[5] N. Di Girolamo,et al. Vitronectin: a migration and wound healing factor for human corneal epithelial cells. , 2014, Investigative ophthalmology & visual science.
[6] K. Taylor,et al. The processing of nanoparticles containing protein for suspension in hydrofluoroalkane propellants. , 2009, International journal of pharmaceutics.
[7] Claus-Michael Lehr,et al. Modeling the human skin barrier--towards a better understanding of dermal absorption. , 2013, Advanced drug delivery reviews.
[8] Vivek T. Natarajan,et al. Multifaceted pathways protect human skin from UV radiation. , 2014, Nature chemical biology.
[9] U. Kompella,et al. Nanoparticles in porous microparticles prepared by supercritical infusion and pressure quench technology for sustained delivery of bevacizumab. , 2013, Molecular pharmaceutics.
[10] J. Reichrath,et al. Quantification of nanoparticle uptake into hair follicles in pig ear and human forearm. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[11] Qiang Zhang,et al. Development of a pulmonary peptide delivery system using porous nanoparticle-aggregate particles for systemic application. , 2013, International journal of pharmaceutics.
[12] Eva Roblegg,et al. Mucus as barrier for drug delivery by nanoparticles. , 2014, Journal of nanoscience and nanotechnology.
[13] Hanns-Christian Mahler,et al. Protein aggregation: pathways, induction factors and analysis. , 2009, Journal of pharmaceutical sciences.
[14] M. Naash,et al. Drug and gene delivery to the back of the eye: from bench to bedside. , 2014, Investigative ophthalmology & visual science.
[15] P. Rigby,et al. Preliminary studies on the development of IgA-loaded chitosan–dextran sulphate nanoparticles as a potential nasal delivery system for protein antigens , 2013, Journal of microencapsulation.
[16] Samir Mitragotri,et al. Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies , 2014, Nature Reviews Drug Discovery.
[17] A. Yamamoto,et al. Absorption Enhancement of Intrapulmonary Administered Insulin by Various Absorption Enhancers and Protease Inhibitors in Rats , 1994, The Journal of pharmacy and pharmacology.
[18] Y. Kawashima,et al. Design and evaluation of poly(DL-lactic-co-glycolic acid) nanocomposite particles containing salmon calcitonin for inhalation. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[19] C. Musabayane,et al. Transdermal Delivery of Insulin by Amidated Pectin Hydrogel Matrix Patch in Streptozotocin-Induced Diabetic Rats: Effects on Some Selected Metabolic Parameters , 2014, PloS one.
[20] F. Bérard,et al. Allergen penetration through the skin. , 2003, European journal of dermatology : EJD.
[21] Jyothi U. Menon,et al. Polymeric nanoparticles for pulmonary protein and DNA delivery. , 2014, Acta biomaterialia.
[22] C. Remuñán-López,et al. Microspheres containing lipid/chitosan nanoparticles complexes for pulmonary delivery of therapeutic proteins. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[23] Michael C Veronesi,et al. Attenuation of kindled seizures by intranasal delivery of neuropeptide-loaded nanoparticles , 2009, Neurotherapeutics.
[24] W. Friess,et al. Optimization of the Fine Particle Fraction of a Lyophilized Lysozyme Formulation for Dry Powder Inhalation , 2013, Pharmaceutical Research.
[25] D. Wirtz,et al. Transport of Polymeric Nanoparticle Gene Carriers in Gastric Mucus , 2004, Biotechnology progress.
[26] V. Torchilin,et al. Current trends in the use of liposomes for tumor targeting. , 2013, Nanomedicine.
[27] M. Alonso,et al. Efficacy of topical cyclosporine-loaded nanocapsules on keratoplasty rejection in the rat. , 1998, Current eye research.
[28] M. Naud,et al. New formulation of vasoactive intestinal peptide using liposomes in hyaluronic acid gel for uveitis. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[29] W. Kreyling,et al. The influence of pulmonary surfactant on nanoparticulate drug delivery systems. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[30] K. Wiesmüller,et al. Topical vaccination with functionalized particles targeting dendritic cells. , 2013, The Journal of investigative dermatology.
[31] H. Takeuchi,et al. Pulmonary delivery of elcatonin using surface-modified liposomes to improve systemic absorption: polyvinyl alcohol with a hydrophobic anchor and chitosan oligosaccharide as effective surface modifiers. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[32] M. Naud,et al. Ocular and systemic bio-distribution of rhodamine-conjugated liposomes loaded with VIP injected into the vitreous of Lewis rats , 2007, Molecular vision.
[33] J. Arias. Liposomes in drug delivery: a patent review (2007 – present) , 2013, Expert opinion on therapeutic patents.
[34] R. Vanbever,et al. Crucial Biopharmaceutical Issues Facing Macromolecular Candidates for Inhalation: The Role of Macrophages in Pulmonary Protein Clearance , 2007 .
[35] Vladimir Kral,et al. Therapeutic application of peptides and proteins: parenteral forever? , 2009, Trends in biotechnology.
[36] C. Dass,et al. Recent developments in liposomes, microparticles and nanoparticles for protein and peptide drug delivery , 2010, Peptides.
[37] N. Nishiyama,et al. Charge-conversional polyionic complex micelles-efficient nanocarriers for protein delivery into cytoplasm. , 2009, Angewandte Chemie.
[38] A. Misra,et al. A preliminary pharmacokinetic study of liposomal leuprolide dry powder inhaler: A technical note , 2005, AAPS PharmSciTech.
[39] C. Selomulya,et al. The effects of engineered nanoparticles on pulmonary immune homeostasis , 2014, Drug metabolism reviews.
[40] M. Foldvari,et al. Evidence for lymphatic transport of insulin by topically applied biphasic vesicles , 2003, The Journal of pharmacy and pharmacology.
[41] R. Gurny,et al. Cyclosporine A delivery to the eye: a pharmaceutical challenge. , 2003, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[42] F. Blank,et al. Opportunities and challenges of the pulmonary route for vaccination , 2011, Expert opinion on drug delivery.
[43] M. Prausnitz,et al. Delivery of salmon calcitonin using a microneedle patch. , 2012, International journal of pharmaceutics.
[44] V. Torchilin,et al. Polymer-Modified Liposomes: From Long-Circulating to Multifunctional , 2014 .
[45] V. Walle,et al. Peptide and protein delivery , 2011 .
[46] P. Cullis,et al. Liposomal drug delivery systems: from concept to clinical applications. , 2013, Advanced drug delivery reviews.
[47] H. Flynn,et al. Drug delivery techniques for treating age-related macular degeneration , 2014, Expert opinion on drug delivery.
[48] S J Prestrelski,et al. Biopharmaceutical powders: particle formation and formulation considerations. , 2000, Current pharmaceutical biotechnology.
[49] A. Sintov,et al. Topical iodine facilitates transdermal delivery of insulin. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[50] M. L. La Rotonda,et al. Improving the efficacy of inhaled drugs in cystic fibrosis: challenges and emerging drug delivery strategies. , 2014, Advanced drug delivery reviews.
[51] P. Diwan,et al. Muco-adhesive multivesicular liposomes as an effective carrier for transmucosal insulin delivery , 2007, Journal of drug targeting.
[52] M. Calderón,et al. Thermosensitive nanogels based on dendritic polyglycerol and N-isopropylacrylamide for biomedical applications , 2011 .
[53] Mizuo Maeda,et al. pH-responsive release of proteins from biocompatible and biodegradable reverse polymer micelles. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[54] Sanjay K. Jain,et al. Peptide and protein delivery using new drug delivery systems. , 2013, Critical reviews in therapeutic drug carrier systems.
[55] C. Remuñán-López,et al. Microencapsulated chitosan nanoparticles for pulmonary protein delivery: in vivo evaluation of insulin-loaded formulations. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[56] Wei Wang,et al. Protein aggregation and its inhibition in biopharmaceutics. , 2005, International journal of pharmaceutics.
[57] Haripriya Kalluri,et al. Transdermal Delivery of Proteins , 2011, AAPS PharmSciTech.
[58] R. Gurny,et al. Novel cyclosporin A formulations using MPEG-hexyl-substituted polylactide micelles: a suitability study. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[59] Shulin Ding. RECENT DEVELOPMENTS IN OPHTHALMIC DRUG DELIVERY , 1998 .
[60] Emanuel Fleige,et al. Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: concepts and applications. , 2012, Advanced drug delivery reviews.
[61] X. Chen,et al. Effective transcutaneous immunization by antigen-loaded flexible liposome in vivo , 2011, International journal of nanomedicine.
[62] W. Seeger,et al. Nano-carriers for DNA delivery to the lung based upon a TAT-derived peptide covalently coupled to PEG-PEI. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[63] L. Illum. Nasal drug delivery--possibilities, problems and solutions. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[64] Robert Langer,et al. Transdermal drug delivery , 2008, Nature Biotechnology.
[65] G. P. Martin,et al. Transdermal drug delivery systems: skin perturbation devices. , 2008, Methods in molecular biology.
[66] R. Steinman,et al. Dendritic cells and the control of immunity , 1998, Nature.
[67] A. Urtti,et al. Current and future ophthalmic drug delivery systems. A shift to the posterior segment. , 2008, Drug discovery today.
[68] Claus-Michael Lehr,et al. The Interplay of Lung Surfactant Proteins and Lipids Assimilates the Macrophage Clearance of Nanoparticles , 2012, PloS one.
[69] A. Almeida,et al. Solid lipid nanoparticles as a drug delivery system for peptides and proteins. , 2007, Advanced drug delivery reviews.
[70] J. McGrath,et al. Anatomy and Organization of Human Skin , 2008 .
[71] Aleksander S Popel,et al. Serpin-derived peptides are antiangiogenic and suppress breast tumor xenograft growth. , 2012, Translational oncology.
[72] Yi-you Huang,et al. Application of galactose-modified liposomes as a potent antigen presenting cell targeted carrier for intranasal immunization. , 2013, Acta biomaterialia.
[73] C. Kitson,et al. Mucus altering agents as adjuncts for nonviral gene transfer to airway epithelium , 2001, Gene Therapy.
[74] J. Nguyen,et al. Biodegradable polymeric nanocarriers for pulmonary drug delivery. , 2008, Expert opinion on drug delivery.
[75] Subhash Chandra Yadav,et al. Development of peptide and protein nanotherapeutics by nanoencapsulation and nanobioconjugation , 2011, Peptides.
[76] J. Wolchok,et al. Antibody therapy of cancer , 2012, Nature Reviews Cancer.
[77] Huibi Xu,et al. Enhanced Nasal Mucosal Delivery and Immunogenicity of Anti-Caries DNA Vaccine through Incorporation of Anionic Liposomes in Chitosan/DNA Complexes , 2013, PloS one.
[78] B. Malaekeh-Nikouei,et al. PREPARATION, CHARACTERIZATION, AND IN VIVO EVALUATION OF NANOLIPOSOMES-ENCAPSULATED BEVACIZUMAB (AVASTIN) FOR INTRAVITREAL ADMINISTRATION , 2009, Retina.
[79] T. Seki,et al. Aerosolized liposomes with dipalmitoyl phosphatidylcholine enhance pulmonary insulin delivery. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[80] S. Smedt,et al. Cystic fibrosis sputum: a barrier to the transport of nanospheres. , 2000, American journal of respiratory and critical care medicine.
[81] J. Patton,et al. The lungs as a portal of entry for systemic drug delivery. , 2004, Proceedings of the American Thoracic Society.
[82] A. Hickey,et al. Liposomal dry powders as aerosols for pulmonary delivery of proteins , 2005, AAPS PharmSciTech.
[83] Juliane Nguyen,et al. Biodegradable polymeric nanocarriers for pulmonary drug delivery , 2008 .
[84] P. Uzor,et al. Perspectives on Transdermal Drug Delivery , 2011 .
[85] L. Reid,et al. Bronchial mucus in health and disease. , 1978, British medical bulletin.
[86] T. Ebensen,et al. Non-invasive delivery of nanoparticles to hair follicles: a perspective for transcutaneous immunization. , 2013, Vaccine.
[87] Qiang Zhang,et al. Prolonged hypoglycemic effect of insulin-loaded polybutylcyanoacrylate nanoparticles after pulmonary administration to normal rats. , 2001, International journal of pharmaceutics.
[88] C. Wood,et al. Therapeutic peptides: technological advances driving peptides into development. , 2006, Current opinion in biotechnology.
[89] Gary P. Martin,et al. Dermal and Transdermal Drug Delivery Systems: Current and Future Prospects , 2006, Drug delivery.
[90] G. Lagoumintzis,et al. Transcutaneous delivery of a nanoencapsulated antigen: induction of immune responses. , 2010, International journal of pharmaceutics.
[91] H. Takeuchi,et al. Surface modification of liposomes using polymer-wheat germ agglutinin conjugates to improve the absorption of peptide drugs by pulmonary administration. , 2013, Journal of pharmaceutical sciences.
[92] G. Borchard,et al. Lectin-Functionalized Liposomes for Pulmonary Drug Delivery: Interaction with Human Alveolar Epithelial Cells , 2001, Journal of drug targeting.
[93] A. Cattaneo,et al. Intranasal delivery of therapeutic proteins for neurological diseases , 2011, Expert opinion on drug delivery.
[94] C. Barnstable,et al. A PEDF N-terminal peptide protects the retina from ischemic injury when delivered in PLGA nanospheres. , 2006, Experimental eye research.
[95] R. Löbenberg,et al. Targeted delivery of nanoparticles for the treatment of lung diseases. , 2008, Advanced drug delivery reviews.
[96] Xin-guo Jiang,et al. Intranasal nanoparticles of basic fibroblast growth factor for brain delivery to treat Alzheimer's disease. , 2014, International journal of pharmaceutics.
[97] M. Foldvari. Biphasic vesicles: a novel topical drug delivery system. , 2010, Journal of biomedical nanotechnology.
[98] E. Fattal,et al. Liposomes for intravitreal drug delivery: a state of the art. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[99] R. Gurny,et al. Ocular biocompatibility of novel Cyclosporin A formulations based on methoxy poly(ethylene glycol)-hexylsubstituted poly(lactide) micelle carriers. , 2011, International journal of pharmaceutics.
[100] C. Lehr,et al. Transfollicular delivery takes root: the future for vaccine design? , 2014, Expert review of vaccines.
[101] H F Edelhauser,et al. Drug delivery for posterior segment eye disease. , 2000, Investigative ophthalmology & visual science.
[102] G. Menon,et al. International Journal of Pharmaceutics , 2012 .
[103] R. Neubert,et al. Dermal Peptide Delivery Using Enhancer Molecules and Colloidal Carrier Systems – Part I: Carnosine , 2012, Skin Pharmacology and Physiology.
[104] T. Ebensen,et al. Efficient nanoparticle-mediated needle-free transcutaneous vaccination via hair follicles requires adjuvantation. , 2015, Nanomedicine : nanotechnology, biology, and medicine.
[105] S. Mangal,et al. Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: effect of mucoadhesive coating on antigen uptake and immune adjuvant activity. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[106] F. Rinaldi,et al. Pulmonary Delivery: Innovative Approaches and Perspectives , 2011 .
[107] Qun Wang,et al. Spray-freeze-dried dry powder inhalation of insulin-loaded liposomes for enhanced pulmonary delivery. , 2008, Journal of drug targeting.
[108] Feroz Jameel,et al. Formulation and process development strategies for manufacturing biopharmaceuticals , 2010 .
[109] V. Préat,et al. Impact of formulation and methods of pulmonary delivery on absorption of parathyroid hormone (1-34) from rat lungs. , 2004, Journal of pharmaceutical sciences.
[110] B. Khoobehi,et al. Liposome-bound cyclosporine: Aqueous and vitreous level after subconjunctival injection , 2004, International Ophthalmology.
[111] B. Khoobehi,et al. Liposome-bound cyclosporine: Clearance after intravitreal injection , 2004, International Ophthalmology.
[112] F. Gu,et al. Development of mucoadhesive drug delivery system using phenylboronic acid functionalized poly(D,L-lactide)-b-dextran nanoparticles. , 2012, Macromolecular bioscience.
[113] Ying-zheng Zhao,et al. Experiment on the feasibility of using modified gelatin nanoparticles as insulin pulmonary administration system for diabetes therapy , 2012, Acta Diabetologica.
[114] G. A. Hofmann,et al. Transdermal iontophoretic delivery of salmon calcitonin. , 2000, International journal of pharmaceutics.
[115] Saurabh Aggarwal,et al. What's fueling the biotech engine? , 2007, Nature Biotechnology.
[116] C. Berkland,et al. Intratracheal administration of a nanoparticle-based therapy with the angiotensin II type 2 receptor gene attenuates lung cancer growth. , 2012, Cancer research.
[117] Mei-Chin Chen,et al. Dissolving polymer microneedle patches for rapid and efficient transdermal delivery of insulin to diabetic rats. , 2013, Acta biomaterialia.
[118] R. B. Campbell,et al. Brain delivery of proteins by the intranasal route of administration: a comparison of cationic liposomes versus aqueous solution formulations. , 2010, Journal of pharmaceutical sciences.
[119] Shohei Sugimoto,et al. Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[120] M. del Río,et al. Topical enzyme-replacement therapy restores transglutaminase 1 activity and corrects architecture of transglutaminase-1-deficient skin grafts. , 2013, American journal of human genetics.
[121] G. Winter,et al. Protein stability in pulmonary drug delivery via nebulization. , 2015, Advanced drug delivery reviews.
[122] Robert N. Weinreb,et al. Ophthalmic drug discovery: novel targets and mechanisms for retinal diseases and glaucoma , 2012, Nature Reviews Drug Discovery.
[123] Lei Sun,et al. Amphiphilic glycopolymer nanoparticles as vehicles for nasal delivery of peptides and proteins. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[124] Bruce K Rubin,et al. Emerging aerosol drug delivery strategies: from bench to clinic. , 2014, Advanced drug delivery reviews.
[125] L. Zhang,et al. Nanoparticles in Medicine: Therapeutic Applications and Developments , 2008, Clinical pharmacology and therapeutics.
[126] J. Mitchell,et al. Recombinant filaggrin is internalized and processed to correct filaggrin deficiency. , 2014, The Journal of investigative dermatology.
[127] C. Chiang,et al. Acyclovir-containing liposomes for potential ocular delivery. Corneal penetration and absorption. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[128] Michael S. Roberts,et al. Modeling the human skin barrier--towards a better understanding of dermal absorption. , 2013, Advanced drug delivery reviews.
[129] M. Foldvari,et al. In vivo sustained dermal delivery and pharmacokinetics of interferon alpha in biphasic vesicles after topical application. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[130] J. Manosroi,et al. Transdermal absorption and stability enhancement of salmon calcitonin by Tat peptide , 2013, Drug development and industrial pharmacy.
[131] Priyanka Ghosh,et al. Challenges and opportunities in dermal/transdermal delivery. , 2010, Therapeutic delivery.
[132] T. Kissel,et al. Controlled pulmonary drug and gene delivery using polymeric nano-carriers. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[133] Xinge Zhang,et al. Mucoadhesive and enzymatic inhibitory nanoparticles for transnasal insulin delivery. , 2014, Nanomedicine.
[134] Saurabh Aggarwal,et al. What's fueling the biotech engine—2012 to 2013 , 2014, Nature Biotechnology.
[135] T. Minko,et al. Innovative strategy for treatment of lung cancer: targeted nanotechnology-based inhalation co-delivery of anticancer drugs and siRNA , 2011, Journal of drug targeting.
[136] Daniel E. Otzen,et al. Protein drug stability: a formulation challenge , 2005, Nature Reviews Drug Discovery.
[137] Costas Kiparissides,et al. Recent advances in nanocarrier-based mucosal delivery of biomolecules. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[138] G. Peyman,et al. Applications of liposomes in ophthalmology. , 2005, Survey of ophthalmology.
[139] A. Turner,et al. Personalizing medicine for metastatic colorectal cancer: current developments. , 2014, World journal of gastroenterology.
[140] B. Bloom,et al. Immunization by a bacterial aerosol , 2008, Proceedings of the National Academy of Sciences.
[141] L. Babiuk,et al. Vaccine delivery: lipid-based delivery systems. , 2000, Journal of biotechnology.
[142] R. Prassl,et al. Association of vasoactive intestinal peptide with polymer-grafted liposomes: structural aspects for pulmonary delivery. , 2007, Biochimica et biophysica acta.
[143] H. Katinger,et al. Increased biological half-life of aerosolized liposomal recombinant human Cu/Zn superoxide dismutase in pigs. , 2008, Journal of aerosol medicine and pulmonary drug delivery.
[144] R. A. Jain,et al. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. , 2000, Biomaterials.
[145] Emmanouil D Karagiannis,et al. A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells , 2008, Proceedings of the National Academy of Sciences.
[146] H. Kohno,et al. Prolonged protective effect of basic fibroblast growth factor-impregnated nanoparticles in royal college of surgeons rats. , 2007, Investigative ophthalmology & visual science.
[147] P. Wertz,et al. Current Understanding of Skin Biology Pertinent to Skin Penetration: Skin Biochemistry , 2013, Skin Pharmacology and Physiology.
[148] C. Haynes,et al. Topical delivery of interferon alpha by biphasic vesicles: evidence for a novel nanopathway across the stratum corneum. , 2010, Molecular pharmaceutics.
[149] B. Freeman,et al. Delivery of superoxide dismutase to pulmonary epithelium via pH-sensitive liposomes. , 1995, The American journal of physiology.
[150] F. Nestle,et al. Mechanisms regulating skin immunity and inflammation , 2014, Nature Reviews Immunology.
[151] M. Khoshayand,et al. The protective effect of albumin on bevacizumab activity and stability in PLGA nanoparticles intended for retinal and choroidal neovascularization treatments. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[152] Samir Mitragotri,et al. Multifunctional nanoparticles for drug delivery and molecular imaging. , 2013, Annual review of biomedical engineering.
[153] S. Cryan,et al. Carrier-based strategies for targeting protein and peptide drugs to the lungs , 2005, The AAPS Journal.
[154] M. Goosen,et al. Transdermal delivery of peptide and protein drugs: An overview , 1995 .
[155] P. Anderson,et al. Interleukin-2 liposomes for primary immune deficiency using the aerosol route. , 2002, International immunopharmacology.
[156] J. Cherng,et al. ENHANCEMENT OF NASAL ABSORPTION OF CALCITONIN LOADED IN LIPOSOMES , 2001, Journal of liposome research.
[157] Nevin Celebi,et al. Controlled delivery of peptides and proteins. , 2007, Current pharmaceutical design.
[158] V. Préat,et al. Pulmonary delivery of growth hormone using dry powders and visualization of its local fate in rats. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[159] P. Campochiaro,et al. Long-term suppression of ocular neovascularization by intraocular injection of biodegradable polymeric particles containing a serpin-derived peptide. , 2013, Biomaterials.
[160] P. Anderson,et al. Interleukin‐2 liposome inhalation therapy is safe and effective for dogs with spontaneous pulmonary metastases , 1997, Cancer.
[161] I. Rico-Lattes,et al. Drug delivery by soft matter: matrix and vesicular carriers. , 2009, Angewandte Chemie.
[162] S. Bale,et al. Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris , 2006, Nature Genetics.
[163] Hans P Merkle,et al. Formulation aspects of biodegradable polymeric microspheres for antigen delivery. , 2005, Advanced drug delivery reviews.
[164] P. Beuzeboc,et al. Targeting HER2 in other tumor types. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.
[165] Maria Palmira Daflon Gremião,et al. Liposomes and micro/nanoparticles as colloidal carriers for nasal drug delivery. , 2006, Current drug delivery.
[166] Praveen Kumar,et al. Transdermal delivery of insulin from a novel biphasic lipid system in diabetic rats. , 2002, Diabetes technology & therapeutics.
[167] B. Luppi,et al. Chitosan-based hydrogels for nasal drug delivery: from inserts to nanoparticles , 2010, Expert opinion on drug delivery.
[168] Daniela Traini,et al. Magnetised Thermo Responsive Lipid Vehicles for Targeted and Controlled Lung Drug Delivery , 2012, Pharmaceutical Research.
[169] R. Vanbever,et al. Delivery strategies for sustained drug release in the lungs. , 2014, Advanced drug delivery reviews.
[170] H. Takeuchi,et al. Pulmonary delivery of insulin with nebulized DL-lactide/glycolide copolymer (PLGA) nanospheres to prolong hypoglycemic effect. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[171] Eun Seong Lee,et al. Long-acting inhalable chitosan-coated poly(lactic-co-glycolic acid) nanoparticles containing hydrophobically modified exendin-4 for treating type 2 diabetes , 2013, International journal of nanomedicine.
[172] T. Gardner,et al. Retinal angiogenesis in development and disease , 2005, Nature.
[173] R. Juliano. Challenges to macromolecular drug delivery. , 2007, Biochemical Society transactions.
[174] Desirée Teijeiro-Osorio,et al. New generation of hybrid poly/oligosaccharide nanoparticles as carriers for the nasal delivery of macromolecules. , 2009, Biomacromolecules.
[175] R. Vanbever,et al. Peptides and Proteins: Pulmonary Absorption , 2013 .
[176] H. Cui,et al. Protein polymer nanoparticles engineered as chaperones protect against apoptosis in human retinal pigment epithelial cells. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[177] Fred Jacobson,et al. Protein aggregation and bioprocessing , 2006, The AAPS Journal.
[178] B. Shekunov,et al. Lipid-based carriers for pulmonary products: preclinical development and case studies in humans. , 2014, Advanced drug delivery reviews.
[179] H. Junginger,et al. Pulmonary delivery of DNA encoding Mycobacterium tuberculosis latency antigen Rv1733c associated to PLGA-PEI nanoparticles enhances T cell responses in a DNA prime/protein boost vaccination regimen in mice. , 2009, Vaccine.
[180] R. Hancock,et al. In vitro aerosol delivery and regional airway surface liquid concentration of a liposomal cationic peptide. , 2001, Journal of pharmaceutical sciences.
[181] Theodore W Randolph,et al. Protein instability and immunogenicity: roadblocks to clinical application of injectable protein delivery systems for sustained release. , 2012, Journal of pharmaceutical sciences.
[182] Zhen Gu,et al. Stimuli-responsive nanomaterials for therapeutic protein delivery. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[183] Clive G. Wilson,et al. Topical and systemic drug delivery to the posterior segments. , 2005, Advanced drug delivery reviews.
[184] Gary M Pollack,et al. Nasal drug administration: potential for targeted central nervous system delivery. , 2005, Journal of pharmaceutical sciences.
[185] L. Kowalczuk,et al. Protein delivery for retinal diseases: From basic considerations to clinical applications , 2010, Progress in Retinal and Eye Research.
[186] Wei Yang,et al. Inhaled nanoparticles--a current review. , 2008, International journal of pharmaceutics.
[187] Shri Kant,et al. Polymeric nanoparticulate system: a potential approach for ocular drug delivery. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[188] Tushar K. Vyas,et al. Intranasal drug delivery for brain targeting. , 2005, Current drug delivery.
[189] W. Hennink,et al. Shifting paradigms: biopharmaceuticals versus low molecular weight drugs. , 2003, International journal of pharmaceutics.
[190] D. Morck,et al. Treatment of corneal defects with delayed re‐epithelization with a medical device/drug delivery system for epidermal growth factor , 2012, Clinical & experimental ophthalmology.
[191] J. Pastor,et al. Polyester Nanocapsules as New Topical Ocular Delivery Systems for Cyclosporin A , 1996, Pharmaceutical Research.